NORTHWOOD, Ohio, Sept. 20, 2012 /PRNewswire/ -- NAMSA, the world's leading medical device research organization, has opened its newest office in Shanghai, China.
(Photo: http://photos.prnewswire.com/prnh/20120920/CL78591 )
The new office will provide improved convenience and efficiency for NAMSA's clients in China and around the world. The Shanghai office allows NAMSA to better support Chinese manufacturers in meeting European and U.S. regulatory requirements. Additionally, the company is better positioned to assist device manufacturers outside China to meet the necessary standards for marketing products in China.
"This expansion benefits all of NAMSA's current and potential clients," said An Liu, general manager, NAMSA China. "Chinese manufacturers can trust in our proven ability to successfully support meeting European and U.S. regulatory requirements, while those manufacturers outside China aiming to distribute products within China can rely on our expertise and proximity for convenient assistance in meeting the country's regulatory demands."
In his new role, Liu is responsible for establishing and developing NAMSA China business. He previously served as director of biostatistics and data management for NAMSA. Before joining NAMSA, Liu served as statistics manager for Medtronic.
"NAMSA is pleased to be in a position to expand and better serve our partners with world-class expertise in regulatory, non-clinical and clinical research services," said Terence Langenderfer, Director of Global Marketing, NAMSA. "It has always been our intention to provide the best strategic guidance and tactical support in the most cost-effective and seamless manner. This expansion in China supports that mission."
To coincide with the opening of the Shanghai office, NAMSA will be presenting at MEDTEC China – the international regulatory conference for the medical device manufacturing industry – on Sept. 26. In addition to Liu, who will present on "Cardiovascular Devices: US FDA Regulatory Requirement and Clinical Trial Design", Dr. Jean Pierre Boutrand, general manager of NAMSA in Lyon, France, and one of NAMSA's top biocompatibility experts, will present on European regulations.
These presenters will be available to meet with participants at MEDTEC China exhibit hall; booth 1501.
NAMSA (www.namsa.com) is a global medical device research organization providing a comprehensive range of services to prove efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. For more than 45 years, NAMSA clients have utilized its testing and consulting services to bring safe and effective therapies to market.
For further information about NAMSA, contact:
Marketing Communications Manager